Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8379)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2021 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yeh H, Chiang CC, Yen TH. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021; 27(26): 4104-4142 [PMID: 34326614 DOI: 10.3748/wjg.v27.i26.4104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i26/4104.htm |
| Number | Citing Articles |
| 1 |
Toyokazu Saito, Satoshi Takakusagi, Hitoshi Takagi, Youzo Yokoyama, Kazuko Kizawa, Kyoko Marubashi, Takashi Kosone, Hiroki Kiyohara, Kei Shibuya, Toshio Uraoka. Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy. Clinical Journal of Gastroenterology 2023; 16(2): 216 doi: 10.1007/s12328-022-01734-1
|
| 2 |
Takanori Ito, Mindie H Nguyen. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes. Journal of Hepatocellular Carcinoma 2023; : 413 doi: 10.2147/JHC.S347959
|
| 3 |
Erlintan Sinaga, Uswatun Hasanah, Feimmy Ruth Pratiwi Sipahutar. Chemopreventive potential of Saurauia vulcani korth in improving Rhodamine B induced hepato-renal carcinoma in Rats. Pharmacological Research - Modern Chinese Medicine 2023; 9: 100336 doi: 10.1016/j.prmcm.2023.100336
|
| 4 |
Liu Yang, Long-fei Zeng, Guo-qing Hong, Qing Luo, Xing Lai, Fu Wang. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/6535009
|
| 5 |
Wu-Po Chao, Shion-Wei Chai, Po-Hsing Chiang, Ta-Chun Chou, Yi-Chan Chen, Ruey-Shyang Soong. Should we change the treatment plan in early hepatocellular carcinoma with chronic kidney disease?. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-01983-y
|
| 6 |
Samantha M. Ruff, Alexander H. Shannon, Joal D. Beane, Timothy M. Pawlik. Highlighting novel targets in immunotherapy for liver cancer. Expert Review of Gastroenterology & Hepatology 2022; 16(11-12): 1029 doi: 10.1080/17474124.2022.2150841
|
| 7 |
Wen-Rui Hao, Tsung-Yeh Yang, Chun-Chao Chen, Kuan-Jie Lin, Chun-Chih Chiu, Yu-Ann Fang, William Jian, Meng-Huan Lei, Hsien-Tang Yeh, Min-Huei Hsu, Nai-Hsuan Chen, Hung-Chang Jong, Jing-Quan Zheng, Ju-Chi Liu. Influenza Vaccination Reduces the Risk of Liver Cancer in Patients with Chronic Kidney Disease: A Nationwide Population-Based Cohort Study. Vaccines 2022; 10(12): 2008 doi: 10.3390/vaccines10122008
|
| 8 |
Yinuo Li, Masashi Mizumoto, Hazuki Nitta, Hiroko Fukushima, Ryoko Suzuki, Sho Hosaka, Yuni Yamaki, Motohiro Murakami, Keiichiro Baba, Masatoshi Nakamura, Toshiki Ishida, Hirokazu Makishima, Takashi Iizumi, Takashi Saito, Haruko Numajiri, Kei Nakai, Satoshi Kamizawa, Chie Kawano, Yoshiko Oshiro, Hideyuki Sakurai. Late Changes in Renal Volume and Function after Proton Beam Therapy in Pediatric and Adult Patients: Children Show Significant Renal Atrophy but Deterioration of Renal Function Is Minimal in the Long-Term in Both Groups. Cancers 2024; 16(9): 1634 doi: 10.3390/cancers16091634
|
| 9 |
Chia-Chu Fu, Yu-Jen Chen, Chien-Wei Su, Cheng-Yi Wei, Chi-Jen Chu, Pei-Chang Lee, Teh-Ia Huo, Yi-Hsiang Huang, Hui-Chun Huang, Jaw-Ching Wu, Ming-Chih Hou. The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B. Journal of the Chinese Medical Association 2023; 86(10): 876 doi: 10.1097/JCMA.0000000000000975
|
| 10 |
Shalin Abraham, Adel Samson. Case report: Successful treatment of a patient undergoing haemodialysis with multifocal hepatocellular carcinoma using atezolizumab and bevacizumab. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1279501
|
| 11 |
Chao Chen, Zhinan Xie, Ying Ni, Yuxi He. Screening immune-related blood biomarkers for DKD-related HCC using machine learning. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1339373
|
| 12 |
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024; 5(2) doi: 10.1002/mco2.474
|
| 13 |
Xinnan Wu, Guangwen Luo, Zhaonian Dong, Wen Zheng, Gengjie Jia. Integrated Pleiotropic Gene Set Unveils Comorbidity Insights across Digestive Cancers and Other Diseases. Genes 2024; 15(4): 478 doi: 10.3390/genes15040478
|
| 14 |
Deok-Gie Kim, Shin Hwang, Jong Man Kim, Je Ho Ryu, Young Kyoung You, Donglak Choi, Bong-Wan Kim, Dong-Sik Kim, Yang Won Nah, Tae-Seok Kim, Jai Young Cho, Geun Hong, Jae Do Yang, Jaryung Han, Suk-Won Suh, Kwan Woo Kim, Yun Kyung Jung, Ju Ik Moon, Jun Young Lee, Sung Hwa Kim, Jae Geun Lee, Myoung Soo Kim, Kwang-Woong Lee, Dong Jin Joo. Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 Month. Journal of Clinical Medicine 2022; 11(14): 4203 doi: 10.3390/jcm11144203
|